Currency: CNY
Period
Q1 FY2024 Earnings
--
1.66B
0.31
Strong Buy
May 11, 2024
Revenue
EPS
EBIT
Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Baiyang Pharmaceutical: Report for the first quarter of 2024
Apr 22 12:00 ET
Baiyang Pharmaceutical: 2023 Annual Report
Baiyang Pharmaceutical: 2023 Annual Report Summary
Baiyang Pharmaceutical: Report for the third quarter of 2023
Oct 26, 2023 12:00 ET
Read more
Updated: May 11, 2024
Buy
Hold
Underperform
Sell
No Data